1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Insmed Incorporated

Insmed Incorporated

INSM
Insmed IncorporatedUS flagNASDAQ Global Select
103.86
USD
+0.13
- -
22.51BMarket Cap

Total Valuation

Insmed Incorporated carries a market capitalization of 22.51B, placing it among publicly traded companies globally. Its enterprise value stands at 33.29B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap22.51B
Enterprise Value33.29B

Share Statistics

Insmed Incorporated currently has 216.52M shares outstanding.

Shares Outstanding216.52M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 41.41, and the price-to-book ratio stands at -5.85.

PE RatioN/A
PS Ratio41.41
PB Ratio-5.85
P/TBV Ratio71.72
P/FCF Ratio-39.02
P/OCF Ratio-37.89

Enterprise Valuation

EV / Sales40.62
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

Insmed Incorporated maintains a current ratio of 4.47, meaning it holds 4.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 82.33, indicating elevated leverage, while an interest coverage ratio of -12.37 demonstrates limited ability to service its debt obligations.

Current Ratio4.47
Quick Ratio3.88
Debt / Equity82.33
Debt / EBITDA-0.61
Interest Coverage-12.37

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-61.04
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.28

Taxes

Income Tax5.58M
Effective Tax RateN/A

Stock Price Statistics

Insmed Incorporated's stock has gained approximately 40.94178% over the past 52 weeks. The 50-day moving average sits at 133.11, while the 200-day moving average is 155.67.

Beta (5Y)N/A
52-Week Price Change40.94178%
50-Day Moving Average133.11
200-Day Moving Average155.67
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Insmed Incorporated generated 819.56M in revenue and converted that into -1.18B in net income, yielding earnings per share of -5.70. EBITDA reached -946.90M, while operating income came in at -965.22M.

Revenue819.56M
Gross Profit670.48M
Operating Income-965.22M
Pretax Income-1.18B
Net Income-1.18B
EBITDA-946.90M
EBIT-965.22M
Earnings Per Share (EPS)-5.70

Balance Sheet

Insmed Incorporated holds 1.22B in cash and equivalents against 580.33M in total debt, resulting in a net debt position of -39.97M. Total book value stands at -5.80B, with working capital of 1.25B providing operational flexibility.

Cash & Cash Equivalents1.22B
Total Debt580.33M
Net Debt-39.97M
Equity (Book Value)-5.80B
Book Value Per Share-27.94
Working Capital1.25B

Cash Flow

Insmed Incorporated produced -895.66M in operating cash flow over the past twelve months. After subtracting -25.97M in capital expenditures, free cash flow totaled -921.63M - equivalent to -4.44 per share.

Operating Cash Flow-895.66M
Capital Expenditures-25.97M
Free Cash Flow-921.63M
FCF Per Share-4.44

Margins

Insmed Incorporated operates with a gross margin of 81.81, reflecting its pricing power and cost economics. The operating margin of -117.77 and net profit margin of -144.44 provide insight into operational efficiency.

Gross Margin81.81
Operating Margin-117.77
Pretax Margin-143.76
Profit Margin-144.44
EBITDA Margin-115.54

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-2.81
FCF Yield-2.56

Stock Splits

Insmed Incorporated's most recent stock split took place on March 3, 2011 with a 10:1 split ratio.

Last Split Date3/3/2011
Split Ratio10:1

Scores

Insmed Incorporated posts an Altman Z-Score of 9.98, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score9.98